01054cam0 22002893 450 TWSOB0000052720201027102537.020020521d1967 |||||ita|0103 baitaIT<<L' >>opera completadi Hogarth pittorepresentazione di Gabriele Baldiniapparati critici e filologici di Gabriele MandelMilanoRizzoli1967120 p.ill.31 cmClassici dell'arte15001LAEC000183392001 *Classici dell'arte15Hogarth, WilliamAF00011783070189070Baldini, GabrieleAF00014056070Mandel, GabrieleAF00010117070ITUNISOB20201027RICAUNISOBUNISOB700|Coll|43|K78346TWSOB00000527M 102 Monografia moderna SBNM700|Coll|43|K000026SI78346ACQUISTOcatenacciUNISOBUNISOB20180417101656.020180417101711.0catenacciOpera completa1675549UNISOB01873nam 2200349 450 991068339010332120230705025954.03-0365-6704-6(CKB)5700000000354328(NjHacI)995700000000354328(EXLCZ)99570000000035432820230705d2023 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierHuman Papillomavirus and Head and Neck Cancer /Heather Walline, editorBasel :MDPI - Multidisciplinary Digital Publishing Institute,2023.1 online resource (268 pages)3-0365-6705-4 In the study of head and neck squamous cell carcinoma (HNSCC), we know that virally induced malignancies behave differently than those generated through other carcinogenic mechanisms. This paradigm extends into differences in tumor growth, treatment response and resistance, as well as invasion and metastasis. The inability to correctly diagnose and appropriately treat HNSCC at early stages has contributed to reduced survival for HNSCC patients, particularly those with HPV-negative disease. The examination of the molecular differences between HPV-positive and HPV-negative HNSCC will provide support for early diagnostic markers and guide appropriate treatment selection to improve patient care and survival.This Special Issue highlights current research efforts to understand the evolving contribution of human papillomavirus in HNSCC.Papillomavirus diseasesPapillomavirus diseases.616.911Walline HeatherNjHacINjHaclBOOK9910683390103321Human Papillomavirus and Head and Neck Cancer3085008UNINA